Robust Genome Editing of Single-Base PAM Targets with Engineered ScCas9 Variants

Pranam Chatterjee, Noah Jakimo, Joseph M. JacobsonbioRxiv 2019 · DOI

TL;DR

This paper introduces engineered variants of the Streptococcus cas9 (ScCas9) enzyme that significantly expand the range of targetable DNA sequences for genome editing. These new variants, Sc+ and Sc++, demonstrate improved editing efficiency and broader PAM specificity, making them powerful tools for applications like base editing and gene regulation.

What Problem Does This Paper Address?

CRISPR-Cas9 technology, a revolutionary tool for genome editing, is limited by the requirement for a specific Protospacer Adjacent Motif (PAM) sequence immediately following the target DNA sequence. The most common Cas9 enzyme from Streptococcus pyogenes (SpCas9) requires an 'NGG' PAM, which restricts its use to only about 25% of the human genome. While recent discoveries have yielded Cas9 variants with relaxed PAM requirements (e.g., recognizing a single 'G'), these still have limitations in terms of efficiency or specificity across different genomic contexts. This paper aims to overcome these limitations by engineering ScCas9 to achieve broader PAM targeting and enhanced editing capabilities.

Methods

The researchers engineered ScCas9 variants by leveraging evolutionary information from related Streptococcus Cas9 orthologs.

  • Sc+ Engineering: They performed sequence alignments and identified a key mutation (T1227K) in the PAM-interacting domain, inspired by S. gordonii Cas9, which is hypothesized to create novel DNA contacts.
  • Sc++ Engineering: Building on Sc+, they introduced a modified loop sequence from S. anginosus Cas9, which maintains a positive charge and includes an "SG" motif, potentially allowing for more flexible interactions with the DNA backbone.
  • PAM Specificity Profiling: A bacterial screen called PAM-SCANR was used to comprehensively determine the PAM sequences recognized by the engineered variants. This involved using a randomized 8-nucleotide PAM library and measuring GFP expression as a proxy for binding.
  • Genome Editing Assays: The nucleolytic and base editing capabilities of the engineered variants were tested in human HEK293T cells. Indel formation (for nucleolytic editing) and C→T base conversions (for base editing) were quantified using Sanger sequencing and specialized algorithms (TIDE and BEEP).
  • Mismatch Tolerance Assay: To assess specificity, a mismatch tolerance assay was performed using sgRNAs with single or double mismatches to a target sequence.

Datasets

The study utilized a randomized 8-bp 5'-NNNNNNNN-3' PAM library for the PAM-SCANR assay. This library represents a comprehensive set of potential PAM sequences for evaluating the specificity of the engineered Cas9 variants. The paper also refers to previously published data and findings related to other Cas9 variants (SpCas9, xCas9-3.7, SpCas9-NG, and wild-type ScCas9) for comparison.

Key Insights and Ideas

  • Leveraging Evolutionary Information: The success in engineering improved ScCas9 variants highlights the power of comparative genomics and evolutionary insights to guide protein engineering for enhanced function.
  • Targeted Mutations for PAM Recognition: Specific amino acid substitutions and loop modifications in key domains of Cas9 can dramatically alter its PAM specificity and improve its targeting range.
  • Sc++ as a Versatile Tool: The engineered Sc++ variant shows promise not only for broad nucleolytic editing but also for base editing applications, suggesting its utility across a spectrum of genome engineering tasks.
  • High-Fidelity Variants are Achievable: The paper demonstrates that modifications known to enhance fidelity in SpCas9 can be successfully ported to engineered ScCas9 variants, offering a path to reduce off-target effects.

Key Results

  • Broader PAM Recognition: Engineered Sc+ and Sc++ variants demonstrated significantly broader PAM recognition compared to wild-type ScCas9 and other engineered variants like SpCas9-NG and xCas9-3.7.
  • Enhanced Editing Efficiency: Sc+ and Sc++ showed improved indel formation percentages across various genomic loci, with nearly a 3-fold improvement on certain 'NNGC-3' targets where other variants were inefficient.
  • Effective Base Editing: The ScCas9+ D10A nickase variant, when incorporated into a base editing system, enabled efficient C→T base conversions, demonstrating its applicability beyond simple DNA cleavage.
  • Reduced Mismatch Tolerance (for high-fidelity variant): A high-fidelity variant of Sc++ (R701A mutation) showed reduced activity on mismatched sequences, indicating improved specificity.

Limitations and Future Work

  • Off-Target Effects: While the high-fidelity variant showed reduced activity on mismatched sequences, the paper acknowledges the ongoing need to further ameliorate mismatch tolerance and ensure minimal off-target editing for broad applications.
  • Context-Specific Performance: The efficiency of the engineered variants might still vary depending on the specific genomic context and target sequence. Further in-depth characterization across diverse cell types and genomic regions would be beneficial.
  • Further Optimization: The authors suggest that continued efforts to improve these enzymes are critical for achieving truly versatile genome engineering and accessing every sequence in the genome. The engineered Sc+ and Sc++ variants are presented as platforms for future development.

Summary updated

Abstract

Programmable CRISPR enzymes are powerful and versatile tools for genome editing. They, however, require a specific protospacer adjacent motif (PAM) flanking the target site, which constrains the accessible sequence space for position-specific genome editing applications, such as base editing and homology-directed repair. For example, the standard Cas9 from Streptococcus pyogenes requires a PAM sequence of 5’-NGG-3’ downstream of its RNA-programmed target. Recently, three separate Cas9 enzymes (xCas9-3.7, SpCas9-NG, and ScCas9) have been independently engineered or discovered to reduce the PAM specificity to a single guanine (G) nucleotide, thus greatly expanding the number of targetable sequences. In this study, we have employed motifs from closely-related orthologs to engineer and optimize ScCas9 to exhibit enhanced genome editing and higher fidelity. Our engineered variants demonstrate superior activity within gene repression and nucleolytic contexts and possess effective base editing capabilities.
BibTeX
@misc{chatterjee2019robust,
  author = {Pranam Chatterjee and Noah Jakimo and Joseph M. Jacobson},
  title = {{Robust Genome Editing of Single-Base PAM Targets with Engineered ScCas9 Variants}},
  year = {2019},
  doi = {10.1101/620351},
  howpublished = {bioRxiv},
}
Figure